However, it induces insulin resistance by the disruption of insulin signaling and induces non-alcoholic fatty liver disease (NAFLD) via the mechanism of hepatic lipid accumulation due to the activity of the ERK/JNK pathway. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.